- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
U3O8 Corp. Announces Uranium Results From Berlin Project in Colombia
Mineweb reported U3O8 Corp.’s (TSXV:UWE,ASX:UTO) stock shot up after announcing positive metallurgical testing at its uranium project.
Mineweb reported U3O8 Corp.’s (TSXV:UWE,ASX:UTO) stock shot up after announcing positive metallurgical testing at its uranium project.
As quoted in the market news:
On Thursday U3O8 Corp (TSXV:UWE) made the case its Berlin uranium project in Colombia can swim, announcing it achieved high recoveries from metallurgical testing of drillhole samples. Ore reacted well to reagants, U3O8 Corp said, and that boded well for modeling the economics of extracting a plethora of products at Berlin, from uranium to yttrium.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.